Niki BioSolutions (NIKI) Stock Analysis

What Niki BioSolutions does

Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.

Key metrics

ETFs linked to NIKI

Broad-market and Healthcare sector ETFs an investor holding Niki BioSolutions is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NIKI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Niki BioSolutions?

Niki BioSolutions trades under the ticker NIKI on NASDAQ.

Which exchange is NIKI listed on?

NIKI is listed on NASDAQ.

What sector does Niki BioSolutions operate in?

Niki BioSolutions is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NIKI in a portfolio?

PortView shows NIKI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.